Overview

Efficacy and Safety of Cladribine Combined With BEAC Pretreatment Regimen in the Treatment of Peripheral T-cell Lymphoma: a Multicenter Clinical Study

Status:
Recruiting

Trial end date:
2025-10-17

Target enrollment:

Participant gender:

Summary

This multi-center clinical study will evaluate the efficacy and safety of Cladribine Combined With BEAC Pretreatment Regimen in the Treatment of Peripheral T-cell Lymphoma.

Phase:

Phase 3

Details

Lead Sponsor:

Ruijin Hospital

Collaborators:

Fujian Medical University Union Hospital
Harbin Hematology and Oncology Institute
Huashan Hospital
Qilu Hospital of Shandong University
RenJi Hospital
Shanxi Province Cancer Hospital
The Affiliated Zhongshan Hospital of Dalian University
The First Affiliated Hospital of Anhui Medical University
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Xinqiao Hospital of Chongqing

Treatments:

Cladribine